Professor MOK Shu-kam, Tony, is Chairman of the Department of Clinical Oncology of the Faculty of Medicine at the Chinese University of Hong Kong, whose research mainly focuses on biomarker and molecular targeted therapy in lung cancer. He has led many important multi-national clinical studies which have officially established targeted therapy as the first-line treatment for EGFR mutation-positive lung cancer, and laid the foundation for personalised medicine for lung cancer. In 2018, he was presented the Lifetime Achievement Award by the European Society for Medical Oncology in recognition of his profound contributions to the world with his research in the field of lung cancer, and is the first Chinese to receive this honour.
Guest: Professor MOK Shu-kam, Tony
Narrator: Ben Pelletier
Guest: Professor MOK Shu-kam, Tony
Narrator: Ben Pelletier
Sign in or sign up to post comments.
Be the first to comment